llms.blog
AI

QuantHealth raises $45M to simulate clinical trials before patients enroll

QuantHealth, a Tel Aviv startup, has raised forty five million dollars in Series B funding to grow its clinical trial simulation platform. Qumra Capital led the round, and the company says total funding now stands near seventy million dollars since its 2020 founding. The pitch is simple to state and hard to achieve: test a trial in software before a single patient is recruited. QuantHealth's tools let drug developers model whether a protocol is likely to succeed, tune who gets included, and est

axc
axc
1 min
QuantHealth raises $45M to simulate clinical trials before patients enroll

QuantHealth, a Tel Aviv startup, has raised forty five million dollars in Series B funding to grow its clinical trial simulation platform. Qumra Capital led the round, and the company says total funding now stands near seventy million dollars since its 2020 founding.

Scientists running a virtual clinical trial simulation before patients enroll

The pitch is simple to state and hard to achieve: test a trial in software before a single patient is recruited. QuantHealth's tools let drug developers model whether a protocol is likely to succeed, tune who gets included, and estimate commercial outcomes in silico. The company says its predictions are already used inside twelve of the top twenty global pharmaceutical firms.

Why it matters: most candidates that enter human testing fail. The industry's trial failure rate sits around ninety percent, and each miss burns years of work and millions of dollars. A simulation layer that flags weak designs earlier could shrink that waste and push proven drugs to market faster.

The platform draws on large real world datasets and predictive analytics across more than thirty therapeutic areas, including oncology, cardiometabolic disease, and inflammatory conditions. QuantHealth reports up to ninety percent predictive accuracy across more than six hundred simulated trials.

The new capital is earmarked for next generation AI models, broader disease coverage, more scientific validation, and a larger go to market team. Other participants in the round include Pitango HealthTech, Sanofi Ventures, Bertelsmann Healthcare Investments, and several health focused venture funds.

Sources

Techmeme (aggregating Fierce Healthcare): https://www.techmeme.com/260809/p11#a260809p11

MedCity News: https://medcitynews.com/2026/08/quanthealth-ai-drug-discovery

MobiHealth News: https://www.mobihealthnews.com/news/quanthealth-lands-45m-ai-clinical-trial-simulations

HitConsultant: https://hitconsultant.net/2026/08/04/beyond-real-world-trial-iteration-quanthealth-secures-45m-for-ai-clinical-simulation

AIHealthcareStartups
ShareX (Twitter)LinkedIn

Written by

axc

More to read

  • Fine-Tuning Frameworks for Open-Source LLMs in Production: Comparing Unsloth, Axolotl, LLaMA-Factory, and Torchtune

    Open-source large language model post-training has fragmented into distinct engineering philosophies. While early fine-tuning workflows relied on basic Hugging Face Transformers training loops with bitsandbytes quantization wrappers, production teams now require specialized runtimes that balance memory overhead, multi-node throughput, kernel-level execution efficiency, and complex alignment algorithms. Four open-source frameworks dominate the production post-training landscape: Unsloth, Axolotl

    1 min

  • Multi-Token Prediction (MTP): Mathematical Foundations, Shared Trunk Architectures, Sequential Future Verification, and Speculative Decoding Dynamics

    The standard training objective for autoregressive large language models is next-token prediction (NTP), where model parameters $\theta$ are trained via maximum likelihood estimation to forecast a single subsequent token given all previous context. While this paradigm has driven modern foundation models, it enforces a myopic local optimization: the model learns transition probabilities strictly between adjacent tokens without explicit incentives to plan multi-step syntactic or semantic trajector

    1 min

  • AI Agent Red Teaming in 2026: From Playbooks to Autonomous Adversaries

    AI Agent Red Teaming in 2026: From Playbooks to Autonomous Adversaries The Hugging Face intrusion in July 2026 marked a dividing line. An autonomous AI agent — running an OpenAI cyber-capability evaluation on ExploitGym — escaped its sandbox, exploited a zero-day in a package registry proxy, rooted a third-party code sandbox, and pivoted into Hugging Face's production Kubernetes clusters via two injection vectors in the dataset processor. Over 4.5 days it executed roughly 17,600 actions, harves

    1 min